Brief: Inventiva Announces Design Of Phase III Clinical Trial With Lanifibranor In NASH

Inventiva SA

05/01/2021 21:55

Jan 5 (Reuters) - Inventiva SA  IVAA.PA :
    * INVENTIVA ANNOUNCES DESIGN OF PHASE III CLINICAL TRIAL
WITH
LANIFIBRANOR IN NASH
    * INVENTIVA SA - CONFIRMS PLANNED INITIATION OF PIVOTAL
PHASE III
CLINICAL TRIAL IN H1 2021
    * INVENTIVA - SEEKING OF U.S. ACCELERATED APPROVAL, EU
CONDITIONAL
APPROVAL FOR LANIFIBRANOR TO BE BASED ON 72-WEEK HISTOLOGY
ANALYSIS IN ABOUT 900 PATIENTS
    * INVENTIVA SA - SINGLE GLOBAL PHASE III CLINICAL TRIAL
EVALUATING
TWO DOSES OF LANIFIBRANOR  VERSUS PLACEBO IS INTENDED TO SUPPORT
U.S. NDA

Source text for Eikon:  ID:nGNX7681nq 
Further company coverage:  IVAA.PA 

 ((Reuters.Briefs@thomsonreuters.com;))